| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/17/2013 | WO2013007765A1 Fused tricyclic compounds for use as inhibitors of janus kinases |
| 01/17/2013 | WO2013007678A1 Use of antagonists targeting metallothionein to treat intestinal inflammation |
| 01/17/2013 | WO2013007053A1 Fully human antibodies against human vegf |
| 01/17/2013 | WO2013007052A1 Fully human antibodies against human cd20 |
| 01/17/2013 | WO2012145254A9 Methods of using inhibitors of rorϒt to treat disease |
| 01/17/2013 | US20130018089 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 01/17/2013 | US20130018081 AChE ANTISENSE OLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENT |
| 01/17/2013 | US20130018070 Modulators of cystic fibrosis transmembrane conductance regulator |
| 01/17/2013 | US20130018067 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | US20130018063 Organic compounds |
| 01/17/2013 | US20130018060 Inhibitors of bruton's tyrosine kinase |
| 01/17/2013 | US20130018057 Quinoline and Quinoxaline Derivatives as Kinase Inhibitors |
| 01/17/2013 | US20130018050 Bi-functional pyrazolopyridine compounds |
| 01/17/2013 | US20130018041 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
| 01/17/2013 | US20130018039 Imidazolyl-imidazoles as kinase inhibitors |
| 01/17/2013 | US20130018034 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors |
| 01/17/2013 | US20130018032 Inhibitors of bruton's tyrosine kinase |
| 01/17/2013 | US20130018031 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists |
| 01/17/2013 | US20130018019 Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activity |
| 01/17/2013 | US20130018017 Quinolinone derivatives as parp and tank inhibitors |
| 01/17/2013 | US20130018003 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
| 01/17/2013 | US20130017998 Novel modified galectin 9 proteins and use thereof |
| 01/17/2013 | US20130017600 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 01/17/2013 | US20130017265 Particles for multiple agent delivery |
| 01/17/2013 | US20130017262 Immediate/delayed drug delivery |
| 01/17/2013 | US20130017255 Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent |
| 01/17/2013 | US20130017253 Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid Compositions |
| 01/17/2013 | US20130017247 Treatment and/or prevention of oral allergic symptoms caused by oral contact with fruits and/or vegetables |
| 01/17/2013 | US20130017226 TNF-A and TWEAK Dual Antagonist for the Prophylaxis and Treatment of Autoimmune Diseases |
| 01/17/2013 | US20130017225 Natural plant products for control of cancer metastasis |
| 01/17/2013 | US20130017224 Nucleic Acid Molecules Encoding Rantes, and Compositions Comprising and Methods of Using the Same |
| 01/17/2013 | US20130017223 Methods and compositions for delivery of nucleic acids |
| 01/17/2013 | US20130017221 Primers for detecting plasmodium |
| 01/17/2013 | US20130017219 Purification of bacterial vesicles |
| 01/17/2013 | US20130017218 Live bacterial vaccine safety |
| 01/17/2013 | US20130017216 Modified Influenza Virus For Monitoring And Improving Vaccine Efficiency |
| 01/17/2013 | US20130017215 Secreted campylobacter flagella coregulated proteins as immunogens |
| 01/17/2013 | US20130017214 Bacteremia-associated antigen from staphylococcus aureus |
| 01/17/2013 | US20130017213 Peptide analogues |
| 01/17/2013 | US20130017211 Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function |
| 01/17/2013 | US20130017208 Anti-IL-6 Antibodies, Compositions, Methods and Uses |
| 01/17/2013 | US20130017204 Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae |
| 01/17/2013 | US20130017203 Methods of treating and preventing staphylococcus aureus infections and associated conditions |
| 01/17/2013 | US20130017199 Simultaneous inhibition of pd-l1/pd-l2 |
| 01/17/2013 | US20130017197 Stabilized antibody preparations and uses thereof |
| 01/17/2013 | US20130017191 Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| 01/17/2013 | US20130017190 Treatment of inflammatory diseases |
| 01/17/2013 | US20130017189 Functionalised Triblock Copolymers and Compositions Containing Such Polymers |
| 01/17/2013 | US20130017188 Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses |
| 01/17/2013 | US20130017174 Compositions and methods for increasing health and reducing pathogenic bacteria in animals |
| 01/17/2013 | US20130017173 Novel compositions and methods for treating inflammatory bowel disease and airway inflammation |
| 01/17/2013 | US20130017170 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/17/2013 | US20130017168 Methods for enhancing the efficacy of il-2 mediated immune responses |
| 01/17/2013 | US20130017149 Pharmaceutical compounds |
| 01/17/2013 | CA2857369A1 Fully human antibodies against human cd20 |
| 01/17/2013 | CA2841356A1 Parenteral norovirus vaccine formulations |
| 01/17/2013 | CA2841080A1 Inhibitors of bruton's tyrosine kinase |
| 01/17/2013 | CA2840460A1 Antibodies that bind to ox40 and their uses |
| 01/17/2013 | CA2840282A1 Use of antagonists targeting metallothionein to treat intestinal inflammation |
| 01/17/2013 | CA2823786A1 Materials for treating and preventing mucosa related disease |
| 01/16/2013 | EP2546330A1 Lactic acid bacterium-containing preparation |
| 01/16/2013 | EP2546234A1 Nitrogeneous heterocyclic derivative and medicine containing the same as an active ingredient |
| 01/16/2013 | EP2545931A1 Herbal therapy for the treatment of food allergy |
| 01/16/2013 | EP2545930A1 Agent for controlling the increase and decrease of lactobacillus bifidus in colon |
| 01/16/2013 | EP2545928A1 Cell preparation containing mesenchymal stem cells, and method for producing same |
| 01/16/2013 | EP2545081A1 Free hexasaccharide isolated from several campylobacter species |
| 01/16/2013 | EP2545058A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/16/2013 | EP2544698A1 Composition comprising probiotic bacteria for use in the treatment of immune disorders |
| 01/16/2013 | CN102884081A Methods of treating autoimmune diseases with DLL4 antagonists |
| 01/16/2013 | CN102884064A Processes for the preparation of S1P1 receptor modulators and crystalline forms thereof |
| 01/16/2013 | CN102884052A Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/16/2013 | CN102884051A Pyrazole compounds as CRTH2 antagonists |
| 01/16/2013 | CN102883750A 选择性整联蛋白抑制剂 Selective integrin inhibitors |
| 01/16/2013 | CN102883731A Infant feeding formulas comprising probiotic micro-organisms |
| 01/16/2013 | CN102875689A Preparation method and application of ophiopogon japonicus polysaccharide |
| 01/16/2013 | CN102875656A Immunoglobuline E (IgE) specific binding polypeptide and medical application thereof |
| 01/16/2013 | CN102875647A Ligand polypeptide and medicine transferring system combined with specificity of CD40L protein |
| 01/16/2013 | CN102875642A Compounds for enzyme inhibition |
| 01/16/2013 | CN102875625A Extraction method of cyclic adenosine monophosphate (cAMP) with antiallergic activity from Chinese date |
| 01/16/2013 | CN102875567A Piperazine compound and preparation and usage thereof |
| 01/16/2013 | CN102875518A Genipin methyl ether, preparation method and medicine application thereof |
| 01/16/2013 | CN102875513A Microcrystal catechin and preparation method thereof |
| 01/16/2013 | CN102875480A Quinazolinone vasoinhibitors, and preparation method and medical application thereof |
| 01/16/2013 | CN102875479A Quinazoline diketone derivative and preparation method, drug compound and application thereof |
| 01/16/2013 | CN102875478A Amine salts of a crth2 antagonist |
| 01/16/2013 | CN102875413A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 01/16/2013 | CN102872460A Refined egg yolk antibody compound for preventing and treating duck reovirus diseases and method for preparing refined egg yolk antibody compound |
| 01/16/2013 | CN102872458A Therapeutic vaccine adjuvant |
| 01/16/2013 | CN102872294A Traditional Chinese medicine composition used for treating low immunity in middle-aged and elderly people |
| 01/16/2013 | CN102872266A Fetus cervi compound medicinal preparation and method for preparing same |
| 01/16/2013 | CN102872257A Chinese angelica and rehmannia blood-enriching tablets |
| 01/16/2013 | CN102872250A Lotion for treating eczema |
| 01/16/2013 | CN102872223A Health protection medicine for enriching blood and prolonging life |
| 01/16/2013 | CN102872206A Traditional Chinese medicine compound capable of improving immunity, resisting fatigue and improving sexual function |
| 01/16/2013 | CN102872178A Preparation method of ginseng oligosaccharide extract and application of ginseng oligosaccharide extract |
| 01/16/2013 | CN102872063A Application of dammarane sapogenin compound |
| 01/16/2013 | CN102872022A Nicotinic receptor agonists for the treatment of inflammatory diseases |
| 01/16/2013 | CN102872012A Compound capable of inhibiting protein kinase and application thereof |
| 01/16/2013 | CN102871991A Application of dimethyldiguanide in drugs taking protective effect on chemoradiotherapy injury |
| 01/16/2013 | CN102871989A External preparation containing either honokiol or pharmaceutically acceptable salt of honokiol and new application |